Wouters C, McIlraith MJ, Ilowite N, Chalom E, Jones OY, Koné-Paut I, . . . Martini A. (2011). Long-term efficacy and safety of adalimumab in 4-12 year old patients with juvenile idiopathic arthritis. BMC.
Chicago Style (17th ed.) CitationWouters C, et al. Long-term Efficacy and Safety of Adalimumab in 4-12 Year Old Patients with Juvenile Idiopathic Arthritis. BMC, 2011.
MLA (9th ed.) CitationWouters C, et al. Long-term Efficacy and Safety of Adalimumab in 4-12 Year Old Patients with Juvenile Idiopathic Arthritis. BMC, 2011.
Warning: These citations may not always be 100% accurate.